Below is an example ADaM dataset designed to support the summarization of concomitant medications. Included are a subset of variables that are commonly inluded to support a basic summary table - for a full list of commonly used and available variables please see Section 2.3.1.1 in the OCCDS section that referecnes Concomitant Medications.
Variable Name | Variable Label | Type | Codelist/Controlled Terms | Core | CDISC Notes |
| STUDYID | Study Identifier | text | Req | CM.STUDYID | |
| USUBJID | Unique Subject Identifier | text | Req | CM.USUBJID | |
| CMTRT | Reported Name of Drug, Med, or Therapy | text | Req | CM.CMTRT | |
| CMDECOD | Standardized Medication Name | text | Perm | CM.CMDECOD | |
| CMCLAS | Medication Class | text | Perm | CM.CMCLAS | |
| ASTDT | Analysis Start Date | integer | Perm | numeric SAS date variable based on CMSTDTC with no imputation for partial dates | |
| ASTDTF | Analysis Start Date Imputation Flag | Perm | |||
| AENDT | Analysis End Date | integer | Perm | numeric SAS date variable based on CMENDTC with no imputation for partial dates | |
| AENDTF | Analysis End Date Imputation Flag | Perm | |||
| ASTDY | Analysis Start Relative Day | integer | Perm | ASTDT-TRTSDT - add one if ASTDT is on or after TRTSDT | |
| AENDY | Analysis End Relative Day | integer | Perm | AENDT-TRTSDT - add one if ASTDT is on or after TRTSDT | |
| AOCCFL | 1st Occurrence within Subject Flag | text | Y | Perm | sort by USUBJID, CMCLAS, CMDECOD, CMSTDTC and then set to Y for the first record |
| AOCCPFL | 1st Occurrence of Preferred Term Flag | text | Y | Perm | sort by USUBJID, CMCLAS, CMDECOD, CMSTDTC and then set to Y for the first record within CMCLAS and CMDECOD |
| AOCC01FL | 1st Occurrence of CMCLAS | text | Y | Perm | sort by USUBJID, CMCLAS, CMDECOD, CMSTDTC and then set to Y for the first record within CMCLAS |
| PREFL | Pre-treatment Flag | text | Y | Cond | |
| ONTRTFL | On Treatment Record Flag | text | Y | Cond | |
| FUPFL | Follow-up Flag | text | Y | Cond | |
| TRTP | Planned Treatment | text | Cond | ADSL.TRT01P | |
| SAFFL | Safety Population Flag | text | Y;N | Cond | ADSL.SAFFL |
| CMDOSE | Dose per Administration | integer | Perm | CM.CMDOSE | |
| CMDOSTXT | Dose Description | text | Perm | CM.CMDOSTXT | |
| CMDOSU | Dose Units | text | Perm | CM.CMDOSU | |
| CMINDC | Indication | text | Perm | CM.CMINDC | |
| CMDOSFRM | Dose Form | text | Perm | CM.CMDOSFRM | |
| CMDOSFRQ | Dosing Frequency per Interval | text | Perm | CM.CMDOSFRQ | |
| CMROUTE | Route of Administration | text | Perm | CM.CMROUTE | |
| CMSTDTC | Start Date/Time of Medication | text | Perm | CM.CMSTDTC | |
| CMENDTC | End Date/Time of Medication | text | Perm | CM.CMENDTC | |
| CMENRF | End Relative to Reference Period | text | Perm | CM.CMENRF | |
| CMSEQ | Sequence Number | integer | Cond | CM.CMSEQ |
STUDYID | USUBJID | CMTRT | CMDECOD | CMCLAS | ASTDT | ASTDTF | AENDT | AENDTF | ASTDY | AENDY | AOCCFL | AOCCPFL | AOCC01FL | PREFL | ONTRTFL | FUPFL | TRTP | SAFFL | CMDOSE | CMDOSTXT | CMDOSU | CMINDC | CMDOSFRM | CMDOSFRQ | CMROUTE | CMSTDTC | CMENDTC | CMENRF | CMSEQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABC123 | A2001 | ASPIRIN | acetylsalicylic acid | ANALGESICS | 21JAN2021 | 22JAN2021 | 1 | 2 | Y | Y | Y | Y | Placebo | Y | 100 | mg | MIGRAINE | TABLET | ONCE | ORAL | 2021-01-21 | 2021-01-22 | 1 | ||||||
| ABC123 | A2008 | DIOVAN | valsartan | ANTIHYPERTENSIVES | 01JAN2004 | M | -6230 | Y | Y | Product A | Y | 20 | mg | HYPERTENSION | TABLET | BID | ORAL | 2004 | AFTER | 2 | |||||||||
| ABC123 | A2008 | ZOLOFT | sertraline | PSYCHOANALEPTICS | 01JAN2010 | D | -4038 | Y | Y | Product A | Y | 50 | mg | PANIC ATTACKS | TABLET | QD | ORAL | 2010-01 | AFTER | 3 | |||||||||
| ABC123 | A2008 | ASTELIN | azelastine | NASAL PREPARATIONS | 26FEB2006 | -5443 | Y | Y | Product A | Y | 2 sprays in each nostril-137 mcg | mcg | INFLUENZA | SPRAY | BID | NASAL | 2006-02-26 | AFTER | 4 | ||||||||||
| ABC123 | A3009 | ASPIRIN | acetylsalicylic acid | ANALGESICS | 01JAN2004 | -6230 | Y | Y | Product B | Y | 100 | mg | PAIN | TABLET | PRN | ORAL | 2004-01-01 | AFTER | 5 |
Overview
Content Tools